Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raed Ventures is a leading Saudi Arabian venture capital firm that focuses on early-stage technology investments across the Middle East and North Africa (MENA) region. Founded in 2015 as the corporate venture capital arm of Almajdouie Holding, the firm primarily leads Seed and Series A rounds for startups disruptive to traditional sectors such as fintech, logistics, and healthcare technology. Beyond financial backing, Raed Ventures provides extensive operational support through its 'Raed Plus' platform, which offers portfolio companies access to strategic partnerships, discounted services, and expert advisory. The firm is a key architect of the Saudi tech ecosystem, with a diverse portfolio that includes notable successes like the fintech unicorn Tabby and the pharmaceutical marketplace Grinta.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raed Ventures.